ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

Toxicology Program Seeks Comment On Substances.

March 23, 2001

OTA Report Concludes Prostate Screening Not Demonstrated To Save Lives

June 2, 1995

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint

December 31, 2010

FASEB urges 10 percent increase for NIH in FY 2005.

January 23, 2004

In Brief: David Kessler Nominated For FDA; Salahuddin Sentenced to Research; B.J. Kennedy Honored

October 26, 1990